307
Racial Variation in Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer: Results from the CEASAR StudyM.D. Tyson, J. Alvarez, T. Koyama, K.E. Hoffman, M.J. Resnick, X.-C. Wu, M.R. Cooperberg,
M. Goodman, S. Greenfield, A.S. Hamilton, M. Hashibe, L.E. Paddock, A. Stroup, V.W. Chen,
D.F. Penson, D.A. Barocas
We observed that the effect of treatment on patient-reported function did not vary
dramatically by race/ethnicity. Compared to white men, African-American men
experienced a somewhat more pronounced decline in urinary incontinence after
radical prostatectomy, but the corresponding changes in bother scores were not
significantly different between the two groups.
315
Re: Diagnostic Accuracy of Multi-parametric Magnetic Resonance Imaging and Transrectal Ultrasound Biopsy in Prostate Cancer (PROMIS): A Paired Validating Confirmatory StudyA. Sood, F. Abdollah
316
Re: Clonal Evolution of Chemotherapy-resistant Urothelial CarcinomaK. Junker, C.-H. Ohlmann
317
Re: Risk of Erectile Dysfunction Associated with Use of 5 -Reductase Inhibitors for Benign Prostatic Hyperplasia or Alopecia: Population Based Studies Using the Clinical Practice Research DatalinkN.K. Gupta, K.T. McVary
318
Re: Mid-term Outcomes After AdvanceXP Male Sling ImplantationE. Rios, L. Martinez-Piñeiro
319
Re: Radiation With or Without Antiandrogen Therapy in Recurrent Prostate CancerM. Beck, S. Hayoz, P. Ghadjar
320
Re: Radiation With or Without Antiandrogen Therapy in Recurrent Prostate CancerB.W. Lamb, J. Violet, S. Siva, D.G. Murphy
e29
Re: Giorgio Gandaglia, Nicola Fossati, Armando Stabile, et al. Radical Prostatectomy in Men with Oligometastatic Prostate Cancer: Results of a Single- institution Series with Long-term Follow-up. Eur Urol 2017;72:289–92Do the Data Violate Kaplan-Meier Assumptions?
http://dx.doi.org/10.1016/j.eururo.2017.01.047P. Mouracade
e31
Reply to Pascal Mouracade’s Letter to the Editor re: Giorgio Gandaglia, Nicola Fossati, Armando Stabile, et al. Radical Prostatectomy in Men with Oligometastatic Prostate Cancer: Results of a Single-institution Series with Long-term Follow-up. Eur Urol 2017;72:289–92. Do the Data Violate Kaplan-Meier Assumptions? http://dx.doi.org/10.1016/j.eururo.2017.01.048G. Gandaglia, N. Fossati, F. Montorsi, A. Briganti
e32
Re: Cesare Cozzarini. Whole-pelvis Radiotherapy in the Radiation Treatment of Intermediate- and High-risk Prostate Cancer: How to Improve the Therapeutic Ratio of a Potentially Effective but still Unsatisfactory Treatment? Eur Urol 2017;71:44–5Preclinical Combinatorial Approach to Enhance Radiotherapy Effects and Reduce
its Morbidity May Be Tested in the Clinic
http://dx.doi.org/10.1016/j.eururo.2017.02.001S. Vale
e34
Reply to Salvador Vale’s Letter to the Editor re: Cesare Cozzarini. Whole-pelvis Radiotherapy in the Radiation Treatment of Intermediate- and High-risk Prostate Cancer: How to Improve the Therapeutic Ratio of a Potentially Effective but still Unsatisfactory Treatment? Eur Urol 2017;71:44–5. Preclinical Combinatory Approach to Enhance Radiotherapy Effects and Reduce its Morbidity may be Tested in the ClinicWider Whole-pelvis Radiotherapy Fields and Enhanced Antitumoral Effect
Mediated by T Lymphocytes: A Legitimate Hypothesis?
http://dx.doi.org/10.1016/j.eururo.2017.02.002C. Cozzarini, F. Benigni, C. Fiorino, A. Mondino, N. Di Muzio
e u r o p e a n u r o l o g y , vo l . 7 2 , n o . 2 , Au g u s t 2 0 1 7
Words ofWisdom
Letters to the Editor
published online
Prostatic Disease




